ATE163540T1 - Retinoid enthaltende, wässrige, gelartige darreichungsform - Google Patents

Retinoid enthaltende, wässrige, gelartige darreichungsform

Info

Publication number
ATE163540T1
ATE163540T1 AT93302926T AT93302926T ATE163540T1 AT E163540 T1 ATE163540 T1 AT E163540T1 AT 93302926 T AT93302926 T AT 93302926T AT 93302926 T AT93302926 T AT 93302926T AT E163540 T1 ATE163540 T1 AT E163540T1
Authority
AT
Austria
Prior art keywords
aqueous
gel
form containing
pharmaceutical form
aqueous gel
Prior art date
Application number
AT93302926T
Other languages
English (en)
Inventor
Richard K Farng
Shirley M Ng
Gerard J Gendimenico
Stanley B Wrobel Jr
James A Mezick
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE163540T1 publication Critical patent/ATE163540T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93302926T 1992-04-16 1993-04-15 Retinoid enthaltende, wässrige, gelartige darreichungsform ATE163540T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86968492A 1992-04-16 1992-04-16

Publications (1)

Publication Number Publication Date
ATE163540T1 true ATE163540T1 (de) 1998-03-15

Family

ID=25354073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93302926T ATE163540T1 (de) 1992-04-16 1993-04-15 Retinoid enthaltende, wässrige, gelartige darreichungsform

Country Status (21)

Country Link
US (1) US5643584A (de)
EP (1) EP0566405B1 (de)
JP (1) JP2779303B2 (de)
KR (1) KR970007901B1 (de)
AT (1) ATE163540T1 (de)
AU (1) AU670777B2 (de)
CA (1) CA2094084C (de)
DE (1) DE69317139T2 (de)
DK (1) DK0566405T3 (de)
ES (1) ES2114588T3 (de)
FI (1) FI931717A7 (de)
GR (1) GR3026597T3 (de)
HU (1) HUT64468A (de)
IL (1) IL105413A (de)
MX (1) MX9302244A (de)
MY (1) MY111791A (de)
NO (1) NO303816B1 (de)
NZ (1) NZ247387A (de)
SG (1) SG52276A1 (de)
TW (1) TW429152B (de)
ZA (1) ZA932653B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481007B1 (de) * 1989-06-07 1997-01-22 BAZZANO, Gail S VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
AU688757B2 (en) * 1993-05-27 1998-03-19 Johnson & Johnson Consumer Products, Inc. Retinoid composition
US5646186A (en) * 1994-05-17 1997-07-08 Johnson & Johnson Consumer Products, Inc. Retinoid composition
FR2718021B1 (fr) * 1994-04-05 1996-06-28 Fabre Pierre Cosmetique Composition topique à base de rétinal.
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
JP3940209B2 (ja) 1996-11-14 2007-07-04 株式会社資生堂 可溶化化粧料
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
SE9801647D0 (sv) * 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
FR2781371B1 (fr) 1998-07-21 2001-04-27 Oreal Composition cosmetique aqueuse transparente a une seule phase
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
WO2000030599A1 (en) * 1998-11-23 2000-06-02 The Procter & Gamble Company Skin deodorizing and sanitizing compositions
US6656456B2 (en) 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
US6262117B1 (en) * 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
US6114348A (en) * 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
FR2807662A1 (fr) * 2000-04-12 2001-10-19 Cll Pharma Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
CN101843601A (zh) * 2000-04-26 2010-09-29 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
US20040087520A1 (en) * 2002-10-25 2004-05-06 Chowdhury Dipak K. Compositions and methods for delivery of therapeutic agents
RU2355393C2 (ru) * 2002-12-12 2009-05-20 Галдерма Ресерч Энд Девелопмент, Снс Депигментирующий водно-спиртовой гель
MXPA05012632A (es) * 2003-05-20 2006-02-22 Ranbaxy Lab Ltd Composiciones farmaceuticas de acitretin.
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
US20060141046A1 (en) * 2004-05-06 2006-06-29 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
AU2005240189A1 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US7662855B2 (en) 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
WO2006065991A2 (en) * 2004-12-17 2006-06-22 Dr. Reddy's Laboratories Ltd. Dispersion for delivering active agents
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
JP2009221164A (ja) 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
HUE056941T2 (hu) * 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
FR2879459B1 (fr) * 2004-12-22 2007-02-16 Galderma Res & Dev Composition comprenant de l'adapalene solubilise avec des cyclodextrines
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
JP5342834B2 (ja) * 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
US7803357B2 (en) * 2006-10-30 2010-09-28 John V Cappello Topical and transdermal treatments using urea formulation
US20090098191A1 (en) * 2007-10-16 2009-04-16 Anderson Christopher G Use of bases to stabilize transdermal formulations
CN101903022A (zh) * 2007-10-18 2010-12-01 梅迪奇斯医药公司 类维生素a和过氧化苯甲酰水凝胶
US20100029765A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
EP2432453A2 (de) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Topische retinoid-lösungen
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
PT2544532T (pt) 2010-03-12 2017-06-02 Monsanto Technology Llc Composições de gel agroquímicas
JP5950428B2 (ja) 2010-08-05 2016-07-13 日東電工株式会社 線維化組織から正常組織を再生するための組成物
EP2825676B1 (de) 2012-03-17 2017-12-20 The Regents of The University of California Schnelle diagnose und personalisierte behandlungen für akne
JP6340162B2 (ja) 2012-12-20 2018-06-06 日東電工株式会社 アポトーシス誘導剤
WO2015063723A1 (en) 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Topical pharmaceutical composition of acitretin
US9976142B2 (en) 2014-04-02 2018-05-22 Nitto Denko Corporation Targeting molecule and a use thereof
AU2014390729B2 (en) 2014-04-07 2018-11-29 Nitto Denko Corporation Novel polymer-based hydrotropes for hydrophobic drug delivery
EP3108875A1 (de) * 2015-06-23 2016-12-28 Galderma Research & Development Zusammensetzungen mit wasserdispergierbaren nanoteilchen einer retinoid-verbindung
CN118121574A (zh) * 2022-12-02 2024-06-04 南京毓浠医药技术有限公司 一种含维a酸组合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
IN142640B (de) * 1975-01-17 1977-08-06 Johnson & Johnson
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
DE3119383A1 (de) * 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
US5476852A (en) * 1989-05-03 1995-12-19 Janssen Pharmaceutica N.V. Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
EP0481007B1 (de) * 1989-06-07 1997-01-22 BAZZANO, Gail S VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL

Also Published As

Publication number Publication date
US5643584A (en) 1997-07-01
NO931390D0 (no) 1993-04-15
FI931717L (fi) 1993-10-17
CA2094084A1 (en) 1993-10-17
ES2114588T3 (es) 1998-06-01
ZA932653B (en) 1994-10-15
SG52276A1 (en) 1998-09-28
AU3685893A (en) 1993-10-21
FI931717A0 (fi) 1993-04-15
DK0566405T3 (da) 1998-09-28
JP2779303B2 (ja) 1998-07-23
HU9301114D0 (en) 1993-07-28
NO303816B1 (no) 1998-09-07
GR3026597T3 (en) 1998-07-31
NO931390L (no) 1993-10-18
DE69317139D1 (de) 1998-04-09
EP0566405A3 (en) 1993-12-15
JPH06100443A (ja) 1994-04-12
NZ247387A (en) 1996-02-27
IL105413A0 (en) 1993-08-18
KR930021210A (ko) 1993-11-22
AU670777B2 (en) 1996-08-01
KR970007901B1 (ko) 1997-05-17
MY111791A (en) 2001-01-31
HUT64468A (en) 1994-01-28
FI931717A7 (fi) 1993-10-17
MX9302244A (es) 1994-05-31
IL105413A (en) 1999-09-22
DE69317139T2 (de) 1998-08-20
EP0566405A2 (de) 1993-10-20
TW429152B (en) 2001-04-11
CA2094084C (en) 1998-06-30
EP0566405B1 (de) 1998-03-04

Similar Documents

Publication Publication Date Title
ATE163540T1 (de) Retinoid enthaltende, wässrige, gelartige darreichungsform
FI935304A7 (fi) Ionisten, samepistettä modifioivien aineiden käyttö hiukkasten kasautumisen estämiseen steriloinnin aikana
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
BR9712491A (pt) Composições cosméticas
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
ATE268587T1 (de) Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
SE9900941D0 (sv) Novel retinoic acid derivatives and their use
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DK0647129T3 (da) Præparat til topisk anvendelse
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
ATE211383T1 (de) Topische aciclovir-zubereitung
IT1244647B (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
RU94036667A (ru) Биоэнергомодулятор
ES2106689B1 (es) Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
MX9704491A (es) Composicion que modula la apoptosis, que comprende un factor que influye en la proporcion intracelular de metional o malondialdehido.
TH61593B (th) สารผสมที่มีเตตราไฮโดรลิพสตาติน
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification